awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37038482-E2F58029-5C57-4A5E-82F2-C77C89F50F44
Q37038482-E2F58029-5C57-4A5E-82F2-C77C89F50F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37038482-E2F58029-5C57-4A5E-82F2-C77C89F50F44
Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies.
P2860
Q37038482-E2F58029-5C57-4A5E-82F2-C77C89F50F44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37038482-E2F58029-5C57-4A5E-82F2-C77C89F50F44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9fb1d99473084a06e39fbd2c6d1293226acb025f
P2860
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction